Tumor PD-L1 expression, immune cell correlates and PD-1+ lymphocytes in sentinel lymph node melanoma metastases

Hojabr Kakavand; Ricardo E. Vilain; James S. Wilmott; Hazel Burke; Jennifer H. Yearley; John F. Thompson; Peter Hersey; Georgina V. Long; Richard A Scolyer

doi:10.1038/modpathol.2015.110

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2015

PD-L1 expression, immune cell correlates, and PD-1+ lymphocytes in sentinel lymph node positive melanoma patients: Implications for adjuvant PD-1 clinical trials.

Hojabr Kakavand, Ricardo E. Vilain, James S. Wilmott, Hazel Burke, Jennifer H. Yearley, John F. Thompson, Peter Hersey, Georgina V. Long, Richard A Scolyer

Article2012

Differential gene expression profiling of primary cutaneous melanoma and sentinel lymph node metastases

Stephen S. Koh, Jia-Perng Jennifer Wei, Xinmin Li, Rong Huang, Ngan Doan, Richard A Scolyer, Alistair J. Cochran, Scott W. Binder

Article2012

Aberrant hypermethylation in primary tumours and sentinel lymph node metastases in paediatric patients with cutaneous melanoma

K T Huynh, Yuki Takei, Calvin Kuo, Richard A Scolyer, Rajmohan Murali, Kelly K. Chong, Ling Takeshima, Sim Ms, D L Morton, Roderick R. Turner, John F. Thompson, Dave S.�B. Hoon

Article2010

Total Sentinel Lymph Node Tumor Size Predicts Nonsentinel Node Metastasis and Survival in Patients with Melanoma

Ali Cadili, Richard A Scolyer, Philip T. Brown, Kelly Dabbs, John F. Thompson

Article2015

PD-L1 Expression and Tumor-Infiltrating Lymphocytes Define Different Subsets of MAPK Inhibitor–Treated Melanoma Patients

Hojabr Kakavand, James S. Wilmott, Alexander M. Menzies, Ricardo E. Vilain, Lauren E. Haydu, Jennifer H. Yearley, John F. Thompson, Richard Kefford, Peter Hersey, Georgina V. Long, Richard A Scolyer